Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 14, 2013; 19(38): 6438-6446
Published online Oct 14, 2013. doi: 10.3748/wjg.v19.i38.6438
Published online Oct 14, 2013. doi: 10.3748/wjg.v19.i38.6438
Table 3 Human epidermalgrowth factor receptor 2 gene status assessed by dual-color in situ hybridization in cases with an immunohistochemistry score of 2+ with HercepTest, 4B5 and SP3 staining on whole-tissue sections and tissue microarrays n (%)
| HER2gene status | Whole-tissue sections | TMAs | ||||
| HercepTest | 4B5 | SP3 | HercepTest | 4B5 | SP3 | |
| Amplified | 0 (0) | 6 (30) | 6 (17.6) | 3 (75) | 3 (100) | 4 (26.6) |
| Not amplified | 1 (100) | 14 (70) | 28 (82.4) | 1 (25) | 0 (0) | 11 (73.4) |
| Total | 1 (100) | 20 (100) | 34 (100) | 4 (100) | 3 (100) | 15 (100) |
- Citation: Abrahão-Machado LF, Jácome AADA, Wohnrath DR, Santos JSD, Carneseca EC, Fregnani JHTG, Scapulatempo-Neto C. HER2 in gastric cancer: Comparative analysis of three different antibodies using whole-tissue sections and tissue microarrays. World J Gastroenterol 2013; 19(38): 6438-6446
- URL: https://www.wjgnet.com/1007-9327/full/v19/i38/6438.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i38.6438